<SEC-DOCUMENT>0001214659-25-018102.txt : 20251217
<SEC-HEADER>0001214659-25-018102.hdr.sgml : 20251217
<ACCEPTANCE-DATETIME>20251216190827
ACCESSION NUMBER:		0001214659-25-018102
CONFORMED SUBMISSION TYPE:	FWP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20251217
DATE AS OF CHANGE:		20251216

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BANK OF MONTREAL /CAN/
		CENTRAL INDEX KEY:			0000927971
		STANDARD INDUSTRIAL CLASSIFICATION:	COMMERCIAL BANKS, NEC [6029]
		ORGANIZATION NAME:           	02 Finance
		EIN:				000000000
		STATE OF INCORPORATION:			A6
		FISCAL YEAR END:			1031

	FILING VALUES:
		FORM TYPE:		FWP
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	333-285508
		FILM NUMBER:		251576876

	BUSINESS ADDRESS:	
		STREET 1:		1 FIRST CANADIAN PLACE
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M5X 1A1
		BUSINESS PHONE:		000-000-0000

	MAIL ADDRESS:	
		STREET 1:		1 FIRST CANADIAN PLACE
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M5X 1A1

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BANK OF MONTREAL /CAN/
		CENTRAL INDEX KEY:			0000927971
		STANDARD INDUSTRIAL CLASSIFICATION:	COMMERCIAL BANKS, NEC [6029]
		ORGANIZATION NAME:           	02 Finance
		EIN:				000000000
		STATE OF INCORPORATION:			A6
		FISCAL YEAR END:			1031

	FILING VALUES:
		FORM TYPE:		FWP

	BUSINESS ADDRESS:	
		STREET 1:		1 FIRST CANADIAN PLACE
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M5X 1A1
		BUSINESS PHONE:		000-000-0000

	MAIL ADDRESS:	
		STREET 1:		1 FIRST CANADIAN PLACE
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M5X 1A1
</SEC-HEADER>
<DOCUMENT>
<TYPE>FWP
<SEQUENCE>1
<FILENAME>d1216251fwp.htm
<DESCRIPTION>ARC 5773
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Registration Statement No.333-285508<BR STYLE="clear: right">
Filed Pursuant to Rule 433</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><BR STYLE="clear: right">
<FONT STYLE="color: red">Subject to Completion, dated December 16, 2025</FONT><BR STYLE="clear: right">
Pricing Supplement to the Prospectus dated March 25, 2025,<BR STYLE="clear: right">
the Prospectus Supplement dated March 25, 2025 and the Product Supplement dated March 25, 2025</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="bmologosm.jpg">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>US$ [ ] </B><BR STYLE="clear: right">
<B>Senior Medium-Term Notes, Series K</B><BR STYLE="clear: right">
<B>Autocallable Barrier Notes with Contingent Coupons due March 24, 2027</B><BR STYLE="clear: right">
<B>Linked to the Least Performing of the NASDAQ-100 Index<SUP>&reg;</SUP> and the shares of Financial Select Sector SPDR<SUP>&reg;</SUP> Fund and the shares
of SPDR<SUP>&reg;</SUP> S&amp;P<SUP>&reg;</SUP> Biotech ETF</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-size: 7.5pt">The notes are designed for investors who are seeking monthly contingent periodic interest payments
(as described in more detail below), as well as a return of principal if the closing level of each of the NASDAQ-100 Index<SUP>&reg;</SUP>, </FONT><FONT STYLE="font-size: 8pt">the
shares of Financial Select Sector SPDR<SUP>&reg;</SUP> Fund and the shares of SPDR<SUP>&reg;</SUP> S&amp;P<SUP>&reg;</SUP> Biotech ETF </FONT><FONT STYLE="font-size: 7.5pt">(each,
a &quot;Reference Asset&quot; and, collectively, the &quot;Reference Assets&quot;) </FONT><FONT STYLE="font-size: 8pt">on any monthly
Observation Date beginning in June 2026 is greater than 100% of its Initial Level (the &ldquo;Call Level&rdquo;). Investors should be
willing to have their notes automatically redeemed prior to maturity, be willing to forego any potential to participate in any increase
in the level of the Reference Assets and be willing to lose some or all of their principal at maturity. </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-size: 8pt">The notes will pay a Contingent Coupon on each Contingent Coupon Payment Date at the Contingent Interest
Rate of 1.2167% per month (approximately 14.60% per annum) if the closing level of each Reference Asset on the applicable monthly Observation
Date is greater than or equal to its Coupon Barrier Level. However, if the closing level of any Reference Asset is less than its Coupon
Barrier Level on an Observation Date, the notes will not pay the Contingent Coupon for that Observation Date. </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-size: 8pt">Beginning on June 18, 2026, if on any Observation Date, the closing level of each Reference Asset is
greater than its Call Level, the notes will be automatically redeemed. On the following Contingent Coupon Payment Date (the &ldquo;Call
Settlement Date&quot;), investors will receive their principal amount plus the Contingent Coupon otherwise due. After the notes are redeemed,
investors will not receive any additional payments in respect of the notes. </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-size: 8pt">The notes do not guarantee any return of principal at maturity. Instead, if the notes are not automatically
redeemed, the payment at maturity will be based on the Final Level of each Reference Asset and whether the closing level of any Reference
Asset has declined from its Initial Level to below its Trigger Level on any trading day during the Monitoring Period (a &ldquo;Trigger
Event&rdquo;), as described below. </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 7.5pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>If the notes are not automatically redeemed and a Trigger Event has occurred and the Final Level of the Least Performing Reference
Asset is less than its Initial Level, investors will lose 1% of the principal amount for each 1% decrease in the level of the Least Performing
Reference Asset from its Initial Level to its Final Level. In such a case, you will receive a cash amount at maturity that is less than
the principal amount, together with the final Contingent Coupon, if payable.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-size: 8pt">Investing in the notes is not equivalent to a hypothetical direct investment in the Reference Assets.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-size: 8pt">The notes will not be listed on any securities exchange.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-size: 8pt">All payments on the notes are subject to the credit risk of Bank of Montreal.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-size: 8pt">The notes will be issued in minimum denominations of $1,000 and integral multiples of $1,000.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-size: 8pt">Our subsidiary, BMO Capital Markets Corp. (&ldquo;BMOCM&rdquo;), is the agent for this offering. See
&ldquo;Supplemental Plan of Distribution (Conflicts of Interest)&rdquo; below.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-size: 8pt">The notes will not be subject to conversion into our common shares or the common shares of any of our
affiliates under subsection 39.2(2.3) of the Canada Deposit Insurance Corporation Act (the &ldquo;CDIC Act&rdquo;).</FONT></TD></TR></TABLE>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Terms of the Notes:<SUP>1</SUP></B></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 9pt">
  <TR>
    <TD STYLE="white-space: nowrap; width: 17%"><FONT STYLE="font-size: 8pt"><B>&nbsp;Pricing Date: </B></FONT></TD>
    <TD STYLE="white-space: nowrap; width: 32%"><FONT STYLE="font-size: 8pt">&nbsp;December 19, 2025 </FONT></TD>
    <TD STYLE="white-space: nowrap; width: 5%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 17%"><FONT STYLE="font-size: 8pt"><B>&nbsp;Valuation Date: </B></FONT></TD>
    <TD STYLE="white-space: nowrap; width: 29%"><FONT STYLE="font-size: 8pt">&nbsp;March 19, 2027 </FONT></TD></TR>
  <TR>
    <TD><FONT STYLE="font-size: 8pt"><B>&nbsp;Settlement Date: </B></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;December 24, 2025 </FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 8pt"><B>&nbsp;Maturity Date: </B></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt"><B>&nbsp;</B>March 24, 2027 </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>1</SUP>Expected. See &ldquo;Key Terms of the Notes&rdquo; below
for additional details.</P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Specific Terms of the Notes:</B></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 9pt">
  <TR>
    <TD STYLE="width: 8%; border: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 7pt"><B>Autocallable <BR>
Number</B></FONT></TD>
    <TD STYLE="width: 8%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 7pt"><B>Reference <BR>
Assets</B></FONT></TD>
    <TD STYLE="width: 8%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 7pt"><B>Ticker <BR>
Symbol</B></FONT></TD>
    <TD STYLE="width: 8%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 7pt"><B>Initial <BR>
Level</B></FONT></TD>
    <TD STYLE="width: 8%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 7pt"><B>Contingent <BR>
Interest Rate</B></FONT></TD>
    <TD STYLE="width: 8%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 7pt"><B>Coupon <BR>
Barrier <BR>
Level</B></FONT></TD>
    <TD STYLE="width: 8%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 7pt"><B>Trigger <BR>
Level</B></FONT></TD>
    <TD STYLE="width: 8%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 7pt"><B>CUSIP</B></FONT></TD>
    <TD STYLE="width: 8%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 7pt"><B>Principal <BR>
Amount</B></FONT></TD>
    <TD STYLE="width: 8%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 7pt"><B>Price to <BR>
Public</B></FONT><SUP>1</SUP></TD>
    <TD STYLE="width: 8%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 7pt"><B>Agent&rsquo;s <BR>
Commission</B></FONT><SUP>1</SUP></TD>
    <TD STYLE="width: 12%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 7pt"><B>Proceeds to <BR>
Bank of <BR>
Montreal</B></FONT><SUP>1</SUP></TD></TR>
  <TR>
    <TD ROWSPAN="3" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 7pt">5773</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;The NASDAQ-100 Index<SUP>&reg;</SUP> </FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;NDX </FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;[ ] </FONT></TD>
    <TD ROWSPAN="3" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid">
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">1.2167% per month (approximately 14.60% per annum)</P>
    <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;[ ], 65.00% of its Initial Level </FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;[ ], 65.00% of its Initial Level </FONT></TD>
    <TD ROWSPAN="3" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 7pt">06376JGQ8</FONT></TD>
    <TD ROWSPAN="3" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 7pt">[ ]</FONT></TD>
    <TD ROWSPAN="3" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 7pt">100%</FONT></TD>
    <TD ROWSPAN="3" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid">
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Up to 0.25%</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[ ]</P>
    <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD>
    <TD ROWSPAN="3" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid">
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">At least 99.75%</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[ ]</P>
    <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;S&amp;P 500 Financials Sector SPDR </FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;XLF </FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;[ ] </FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;[ ], 65.00% of its Initial Level </FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;[ ], 65.00% of its Initial Level </FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;S&amp;P Biotech SPDR </FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;XBI </FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;[ ] </FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;[ ], 65.00% of its Initial Level </FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;[ ], 65.00% of its Initial Level </FONT></TD></TR>
  </TABLE>
<P STYLE="margin: 0pt 0; font: 6pt Times New Roman, Times, Serif"><SUP>1</SUP> The total &ldquo;Agent&rsquo;s Commission&rdquo; and &ldquo;Proceeds
to Bank of Montreal&rdquo; to be specified above will reflect the aggregate amounts at the time Bank of Montreal establishes its hedge
positions on or prior to the Pricing Date, which may be variable and fluctuate depending on market conditions at such times. Certain dealers
who purchased the notes for sale to certain fee-based advisory accounts may forego some or all of their selling concessions, fees or commissions.
The public offering price for investors purchasing the notes in these accounts may be between $997.50 and $1,000 per $1,000 in principal
amount. We or one of our affiliates may also pay a referral fee to certain dealers in connection with the distribution of the notes.</P>

<P STYLE="font: 6pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B><I>Investing in the notes involves risks, including
those described in the &ldquo;Selected Risk Considerations&rdquo; section beginning on page P-5 hereof, the &ldquo;Additional Risk Factors
Relating to the Notes&rdquo; section beginning on page PS-6 of the product supplement, and the &ldquo;Risk Factors&rdquo; section beginning
on page S-1 of the prospectus supplement and on page 8 of the prospectus.</I></B></P>

<P STYLE="font: 6pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><I>Neither the Securities and Exchange Commission
nor any state securities commission has approved or disapproved of these notes or passed upon the accuracy of this document, the product
supplement, the prospectus supplement or the prospectus. Any representation to the contrary is a criminal offense. The notes will be our
unsecured obligations and will not be savings accounts or deposits that are insured by the United States Federal Deposit Insurance Corporation,
the Deposit Insurance Fund, the Canada Deposit Insurance Corporation or any other governmental agency or instrumentality or other entity.</I></P>

<P STYLE="font: 6pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On the date hereof, based on the terms set forth
above, the estimated initial value of the notes is $992.40 per $1,000 in principal amount. The estimated initial value of the notes on
the Pricing Date may differ from this value but will not be less than $945.00 per $1,000 in principal amount. However, as discussed in
more detail below, the actual value of the notes at any time will reflect many factors and cannot be predicted with accuracy.</P>

<P STYLE="font: 6pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>BMO CAPITAL MARKETS</B></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"></TD><TD STYLE="text-align: right; width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Key Terms of the Notes:</B></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 9pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 25%">Reference Assets:</TD>
    <TD STYLE="width: 75%">&nbsp;The NASDAQ-100 Index<SUP>&reg;</SUP> (ticker symbol &quot;NDX&quot;) and the shares of Financial Select Sector SPDR<SUP>&reg;</SUP> Fund (ticker symbol &quot;XLF&quot;) and the shares of SPDR<SUP>&reg;</SUP> S&amp;P<SUP>&reg;</SUP> Biotech ETF (ticker symbol &quot;XBI&quot;). See &quot;The Reference Assets&quot; below for additional information.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Underlying Index:</TD>
    <TD>With respect to Financial Select Sector SPDR<SUP>&reg;</SUP> Fund, the Financial Select Sector Index, and with respect to SPDR<SUP>&reg;</SUP> S&amp;P<SUP>&reg;</SUP> Biotech ETF, the S&amp;P<SUP>&reg;</SUP> Biotechnology Select Industry<SUP>&reg;</SUP> Index.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Contingent Coupons:</TD>
    <TD>If the closing level of each Reference Asset on an Observation Date is greater than or equal to its Coupon Barrier Level, a Contingent Coupon will be paid on the corresponding Contingent Coupon Payment Date at the Contingent Interest Rate, subject to the automatic redemption feature.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Contingent Interest Rate:</TD>
    <TD>1.2167% per month (approximately 14.60% per annum), if payable. Accordingly, each Contingent Coupon, if payable, will equal $12.167 for each $1,000 in principal amount.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Observation Dates:<SUP>1</SUP></TD>
    <TD>Three trading days prior to each scheduled Contingent Coupon Payment Date.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Contingent Coupon Payment <BR>
Dates:<SUP>1</SUP></TD>
    <TD>Interest, if payable, will be paid on the 24th day of each month (or, if such day is not a business day, the next following business day), beginning on January 24, 2026 and ending on the Maturity Date, subject to the automatic redemption feature.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Automatic Redemption:</TD>
    <TD>Beginning on June 18, 2026, if, on any Observation Date, the closing level of each Reference Asset is greater than its Call Level, the notes will be automatically redeemed. No further amounts will be owed to you under the Notes.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Payment upon Automatic <BR>
Redemption:</TD>
    <TD>If the notes are automatically redeemed, then, on the Call Settlement Date, investors will receive their principal amount plus the Contingent Coupon otherwise due.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Call Settlement Date:<SUP>1</SUP></TD>
    <TD>If the notes are automatically redeemed, the Contingent Coupon Payment Date immediately following the relevant Observation Date.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Payment at Maturity:</TD>
    <TD>
    <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">If the notes are not automatically redeemed, the payment at maturity
    for the notes is based on the performance of the Reference Assets.</P>
    <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">You will receive $1,000 for each $1,000 in principal amount of the note,
    unless (a) a Trigger Event has occurred and (b) the Final Level of the Least Performing Reference Asset is less than its Initial Level.</P>
    <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">If a Trigger Event has occurred and the Final Level of the Least Performing
    Reference Asset is less than its Initial Level, you will receive at maturity, for each $1,000 in principal amount of your notes, a cash
    amount equal to:</P>
    <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">$1,000 + ($1,000 x Percentage Change of the Least
    Performing Reference Asset)</P>
    <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>This amount will be less than the principal amount
    of your notes, and may be zero.</B></P>
    <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">You will also receive the final Contingent Coupon, if payable.</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Trigger Event:<SUP>2</SUP></TD>
    <TD>A Trigger Event will be deemed to occur if the closing level of any Reference Asset is less than its Trigger Level on any trading day during the Monitoring Period.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Least Performing Reference Asset:</TD>
    <TD>The Reference Asset with the lowest Percentage Change.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Monitoring Period:</TD>
    <TD>The period from the Pricing Date to and including the Valuation Date.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Percentage Change:</TD>
    <TD>
    <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">With respect to each Reference Asset, the quotient, expressed as a percentage,
    of the following formula:</P>
    <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>(Final Level - Initial Level)</U><BR STYLE="clear: right">
    Initial Level</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Initial Level:<SUP>2</SUP></TD>
    <TD>With respect to each Reference Asset, the closing level of that Reference Asset on the Pricing Date.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Coupon Barrier Level:<SUP>2</SUP></TD>
    <TD>With respect to each Reference Asset, 65.00% of its Initial Level.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Trigger Level:<SUP>2</SUP></TD>
    <TD>With respect to each Reference Asset, 65.00% of its Initial Level.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Call Level:<SUP>2</SUP></TD>
    <TD>With respect to each Reference Asset, 100% of its Initial Level.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Final Level:</TD>
    <TD>With respect to each Reference Asset, the closing level of that Reference Asset on the Valuation Date.</TD></TR>
  </TABLE>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="text-align: right; width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 9pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 25%">Pricing Date:<SUP>1</SUP></TD>
    <TD STYLE="width: 75%">December 19, 2025</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Settlement Date:<SUP>1</SUP></TD>
    <TD>December 24, 2025</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Valuation Date:<SUP>1</SUP></TD>
    <TD>March 19, 2027</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Maturity Date:<SUP>1</SUP></TD>
    <TD>March 24, 2027</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Calculation Agent:</TD>
    <TD>BMOCM</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Selling Agent:</TD>
    <TD>BMOCM</TD></TR>
  </TABLE>
<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>1</SUP> Expected and subject to the occurrence of a market disruption
event, as described in the accompanying product supplement. If we make any change to the expected Pricing Date and Settlement Date, the
Contingent Coupon Payment Dates (and therefore the Observation Dates and potential Call Settlement Dates), the Valuation Date and Maturity
Date will be changed so that the stated term of the notes remains approximately the same.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>2</SUP> As determined by the calculation agent and subject to adjustment
in certain circumstances. See &quot;General Terms of the Notes &mdash; Anti-dilution Adjustments to a Reference Asset that Is an Equity
Security (Including Any ETF)&rdquo; and &ldquo;&mdash; Adjustments to a Reference Asset that Is an ETF&rdquo; in the product supplement
with respect to the Financial Select Sector SPDR<SUP>&reg;</SUP> Fund and to the SPDR<SUP>&reg;</SUP> S&amp;P<SUP>&reg;</SUP> Biotech ETF and &quot;General Terms of the
Notes - Adjustments to a Reference Asset that is an Index&quot; in the product supplement with respect to the NASDAQ-100 Index<SUP>&reg;</SUP> for
additional information.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="text-align: right; width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Additional Terms of the Notes</B></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">You should read this document together with the
product supplement dated March 25, 2025, the prospectus supplement dated March 25, 2025 and the prospectus dated March 25, 2025. <B>This
document, together with the documents listed below, contains the terms of the notes and supersedes all other prior or contemporaneous
oral statements as well as any other written materials including preliminary or indicative pricing terms, correspondence, trade ideas,
structures for implementation, sample structures, fact sheets, brochures or other educational materials of ours or the agent.</B> You
should carefully consider, among other things, the matters set forth in Additional Risk Factors Relating to the Notes in the product supplement,
as the notes involve risks not associated with conventional debt securities. We urge you to consult your investment, legal, tax, accounting
and other advisers before you invest in the notes.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">You may access these documents on the SEC website
at www.sec.gov as follows (or if such address has changed, by reviewing our filings for the relevant date on the SEC website):</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">Product supplement dated March 25, 2025:<BR STYLE="clear: right">
<A HREF="https://www.sec.gov/Archives/edgar/data/927971/000121465925004743/b324250424b2.htm">https://www.sec.gov/Archives/edgar/data/927971/000121465925004743/b324250424b2.htm</A></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">Prospectus supplement dated March 25, 2025 and prospectus
dated March 25, 2025:<BR STYLE="clear: right">
<A HREF="https://www.sec.gov/Archives/edgar/data/927971/000119312525062081/d840917d424b5.htm">https://www.sec.gov/Archives/edgar/data/927971/000119312525062081/d840917d424b5.htm</A></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our Central Index Key, or CIK, on the SEC website
is 927971. As used in this document, &quot;we&quot;, &quot;us&quot; or &quot;our&quot; refers to Bank of Montreal.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have filed a registration statement (including
a prospectus) with the SEC for the offering to which this document relates. Before you invest, you should read the prospectus in that
registration statement and the other documents that we have filed with the SEC for more complete information about us and this offering.
You may obtain these documents free of charge by visiting the SEC's website at http://www.sec.gov. Alternatively, we will arrange to send
to you the prospectus (as supplemented by the prospectus supplement and product supplement) if you request it by calling our agent toll-free
at 1-877-369-5412.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="text-align: right; width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Selected Risk Considerations</B></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">An investment in the notes involves significant
risks. Investing in the notes is not equivalent to investing directly in the Reference Assets. These risks are explained in more detail
in the &ldquo;Additional Risk Factors Relating to the Notes&rdquo; section of the product supplement.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Risks Related to the Structure or Features of the Notes</B></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B>Your investment in the notes may result in a loss. </B> &mdash; The notes do not guarantee any return of principal. If the notes
are not automatically redeemed, the payment at maturity will be based on the Final Level of each Reference Asset and whether a Trigger
Event has occurred. If the closing level of any Reference Asset is less than its Trigger Level on any trading day during the Monitoring
Period, a Trigger Event will occur. If a Trigger Event occurs and the Final Level of any Reference Asset is less than its Initial Level,
you will lose 1% of the principal amount for each 1% that the Final Level of the Least Performing Reference Asset is less than its Initial
Level. In such a case, you will receive at maturity a cash payment that is less than the principal amount of the notes and may be zero.
<B>Accordingly, you could lose your entire investment in the notes.</B></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B>The protection provided by the Trigger Level may terminate on any trading day during the Monitoring Period.</B> &mdash; If the
closing level of any Reference Asset is less than its Trigger Level on any trading day during the Monitoring Period and the Final Level
of any Reference Asset is less than its Initial Level, you will suffer a 1% loss on your investment for each 1% that the Final Level is
less than the Initial Level. You will be subject to this potential loss of principal even if, after the Trigger Event occurs, the level
of any Reference Asset increases above its Trigger Level.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B>You may not receive any Contingent Coupons with respect to your notes.</B> &mdash; We will not necessarily make periodic interest
payments on the notes. If the closing level of any Reference Asset on an Observation Date is less than its Coupon Barrier Level, we will
not pay you the Contingent Coupon applicable to that Observation Date. If the closing level of a Reference Asset is less than its Coupon
Barrier Level on each of the Observation Dates, we will not pay you any Contingent Coupons during the term of the notes, and you will
not receive a positive return on the notes. Generally, this non-payment of any Contingent Coupons will coincide with a greater risk of
principal loss on your notes.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B>Your notes are subject to automatic early redemption.</B> &mdash; We will redeem the notes if the closing level of each Reference
Asset on any Observation Date is greater than its Call Level. Following an automatic redemption, you will not receive any additional Contingent
Coupons and may not be able to reinvest your proceeds in an investment with returns that are comparable to the notes. Furthermore, to
the extent you are able to reinvest such proceeds in an investment with a comparable return for a similar level of risk, you may incur
transaction costs such as dealer discounts and hedging costs built into the price of the new notes.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B>Your return on the notes is limited to the Contingent Coupons, if any, regardless of any increase in the level of any Reference
Asset. </B> &mdash; You will not receive a payment at maturity with a value greater than your principal amount plus the final Contingent
Coupon, if payable. In addition, if the notes are automatically redeemed, you will not receive a payment greater than the principal amount
plus the applicable Contingent Coupon, even if the Final Level of one or more Reference Assets exceeds its Call Level by a substantial
amount. Accordingly, your maximum return on the applicable notes is limited to the potential return represented by the Contingent Coupons.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B>Whether you receive any Contingent Coupons and your payment at maturity may be determined solely by reference to the least performing
Reference Asset, even if any other Reference Assets perform better. </B> - We will only make each Contingent Coupon payment on the notes
if the closing level of each Reference Asset on the applicable Observation Date exceeds the applicable Coupon Barrier, even if the levels
of any other Reference Assets have increased significantly. Similarly, if a Trigger Event occurs with respect to any Reference Asset and
the Final Level of any Reference Asset is less than its Initial Level, your payment at maturity will be determined by reference to the
performance of the Least Performing Reference Asset. Even if the levels of any other Reference Assets have increased over the term of
the notes, or have experienced a decline that is less than that of the Least Performing Reference Asset, your return at maturity will
only be determined by reference to the performance of the Least Performing Reference Asset if a Trigger Event occurs.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B>The payments on the notes will be determined by reference to each Reference Asset individually, not to a basket, and the payments
on the notes will be based on the performance of the least performing Reference Asset. </B> &mdash; Whether each Contingent Coupon is
payable, and the payment at maturity if a Trigger Event occurs, will be determined only by reference to the performance of the least performing
Reference Asset as of the applicable Observation Date and/or Valuation Date, regardless of the performance of any other Reference Assets.
The notes are not linked to a weighted basket, in which the risk may be mitigated and diversified among each of the basket components.
For example, in the case of notes linked to a weighted basket, the return would depend on the weighted aggregate performance of the basket
components reflected as the basket return. As a result, a decrease of the level of one basket component could be mitigated by the increase
of the level of the other basket components, as scaled by the weighting of that basket component. However, in the case of the notes, the
individual performance of each Reference Asset will not be combined, and the performance of one Reference Asset will not be mitigated
by any positive performance of any other Reference Assets. Instead, your receipt of Contingent Coupon payments on the notes will depend
on the level of each Reference Asset on each Observation Date, and your return at maturity will depend solely on the Final Level of the
Least Performing Reference Asset if a Trigger Event occurs.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B>Your return on the notes may be lower than the return on a conventional debt security of comparable maturity. </B> &mdash; The
return that you will receive on your notes, which could be negative, may be less than the return you could earn on other investments.
The notes do not provide for fixed interest payments and you may not receive any Contingent Coupons over the term of the notes. Even if
you do receive one or more Contingent Coupons and your return on the notes is positive, your return may be less than the return you would
earn if you bought a conventional senior interest bearing debt security of ours with the same maturity or if you invested directly in
the Reference Assets. Your investment may not reflect the full opportunity cost to you when you take into account factors that affect
the time value of money.</TD></TR></TABLE>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="text-align: right; width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B>A higher Contingent Interest Rate or lower Trigger Levels or Coupon Barrier Levels may reflect greater expected volatility of the
Reference Assets, and greater expected volatility generally indicates an increased risk of loss at maturity. </B> &mdash; The economic
terms for the notes, including the Contingent Interest Rate, Coupon Barrier Levels and Trigger Levels, are based, in part, on the expected
volatility of the Reference Assets at the time the terms of the notes are set. &ldquo;Volatility&rdquo; refers to the frequency and magnitude
of changes in the level of a Reference Asset. The greater the expected volatility of the Reference Assets as of the Pricing Date, the
greater the expectation is as of that date that the closing level of a Reference Asset could be less than its Coupon Barrier Level on
any Observation Date and that a Trigger Event could occur and, as a consequence, indicates an increased risk of not receiving a Contingent
Coupon and an increased risk of loss, respectively. All things being equal, this greater expected volatility will generally be reflected
in a higher Contingent Interest Rate than the yield payable on our conventional debt securities with a similar maturity or on otherwise
comparable securities, and/or a lower Trigger Levels and/or Coupon Barrier Levels than those terms on otherwise comparable securities.
Therefore, a relatively higher Contingent Interest Rate may indicate an increased risk of loss. Further, relatively lower Trigger Levels
and/or Coupon Barriers may not necessarily indicate that the notes have a greater likelihood of a return of principal at maturity and/or
paying Contingent Coupons. You should be willing to accept the downside market risk of the Reference Assets and the potential to lose
a significant portion or all of your initial investment.</TD></TR></TABLE>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Risks Related to the Reference Assets</B></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B>Owning the notes is not the same as owning shares of any Reference Assets, making a hypothetical direct investment in any Reference
Assets or owning a security directly linked to the Reference Assets.</B> &mdash; The return on your notes will not reflect the return
you would realize if you actually owned shares of any Reference Assets, made a hypothetical direct investment in any Reference Assets
or the underlying securities of any Reference Assets, or owned a security directly linked to the performance of the Reference Assets or
the underlying securities of the Reference Assets and held that investment for a similar period. Your notes may trade quite differently
from the Reference Assets. Changes in the level of a Reference Asset may not result in comparable changes in the market value of your
notes. Even if the levels of the Reference Assets increase during the term of the notes, the market value of the notes prior to maturity
may not increase to the same extent. It is also possible for the market value of the notes to decrease while the levels of the Reference
Assets increase. In addition, any dividends or other distributions paid on a Reference Asset will not be reflected in the amount payable
on the notes.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B>You will not have any shareholder rights and will have no right to receive any shares of any Reference Asset (or any company included
in a Reference Asset) at maturity. </B> &mdash; Investing in your notes will not make you a holder of any shares of any Reference Asset
or any securities held by or included in the Reference Assets. Neither you nor any other holder or owner of the notes will have any voting
rights, any right to receive dividends or other distributions, or any other rights with respect to any Reference Asset or such underlying
securities.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B>No delivery of shares of the Reference Assets. </B> &mdash; The notes will be payable only in cash. You should not invest in the
notes if you seek to have the shares of a Reference Asset delivered to you at maturity.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B>Changes that affect an Underlying Index will affect the market value of the notes and the amount you will receive at maturity.
</B> &mdash; With respect to a Reference Asset that is an ETF, the policies of the applicable index sponsor concerning the calculation
of the applicable Underlying Index, additions, deletions or substitutions of the components of the applicable Underlying Index and the
manner in which changes affecting those components, such as stock dividends, reorganizations or mergers, may be reflected in the applicable
Reference Asset and, therefore, could affect the share price of the Reference Asset, the amounts payable on the notes and the market value
of the notes prior to maturity. The amount payable on the notes and their market value could also be affected if the applicable index
sponsor changes these policies, for example, by changing the manner in which it calculates the applicable Underlying Index, or if the
applicable index sponsor discontinues or suspends the calculation or publication of the applicable Underlying Index.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B>We have no affiliation with any index sponsor and will not be responsible for any index sponsor's actions.</B> &mdash; The sponsors
of any Reference Asset or Underlying Index, as applicable, are not our affiliates and will not be involved in the offering of the notes
in any way. Consequently, we have no control over the actions of any index sponsor, including any actions of the type that would require
the calculation agent to adjust the payment to you at maturity. The index sponsors have no obligation of any sort with respect to the
notes. Thus, the index sponsors have no obligation to take your interests into consideration for any reason, including in taking any actions
that might affect the value of the notes. None of our proceeds from the issuance of the notes will be delivered to any index sponsor of
any Reference Asset or any Underlying Index.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B>Adjustments to a Reference Asset that is an ETF could adversely affect the notes. </B> &mdash; The sponsor and advisor of each
ETF Reference Asset is responsible for calculating and maintaining that Reference Asset. The sponsor and advisor of each ETF Reference
Asset can add, delete or substitute the stocks comprising that Reference Asset or make other methodological changes that could change
the share price of the applicable Reference Asset at any time. If one or more of these events occurs, the calculation of the amount payable
at maturity may be adjusted to reflect such event or events. Consequently, any of these actions could adversely affect the amount payable
at maturity and/or the market value of the notes.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B>Changes that affect a Reference Asset that is an index could adversely affect the notes. </B> &mdash; The policies of the sponsor
of each index Reference Asset with respect to the applicable Reference Asset concerning the calculation of the applicable Reference Asset,
additions, deletions or substitutions of the components of the applicable Reference Asset and the manner in which changes affecting those
components, such as stock dividends, reorganizations or mergers, may be reflected in the applicable Reference Asset and, therefore, could
affect the level of the applicable Reference Asset, the amount payable on the notes at maturity and the market value of the notes prior
to maturity. The amount payable on the notes and their market value could also be affected if an index sponsor changes these policies,
for example, by changing the manner in which it calculates the applicable Reference Asset, or if an index sponsor discontinues or suspends
the calculation or publication of the applicable Reference Asset. If an index sponsor discontinues publication of a Reference Asset, the
calculation agent may select a successor index (and make any corresponding adjustments to the applicable Initial Level, Coupon Barrier
Level and Trigger Level) which will be used as a substitute for the relevant Reference Asset for all purposes with respect to the notes.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B>We and our affiliates do not have any affiliation with any applicable investment advisor or any Reference Asset Issuer and are
not responsible for their public disclosure of information. </B> &mdash; The investment advisor of each ETF Reference Asset advises the
issuer of the applicable Reference Asset (each, a &ldquo;Reference Asset Issuer&rdquo; and, collectively, the &ldquo;Reference Asset Issuers&rdquo;)
on various matters, including matters relating to the policies, maintenance and calculation of the applicable Reference Asset. We and
our affiliates are not affiliated with the investment advisor of any Reference Asset or any Reference Asset Issuer in any way and have
no ability to control or predict their actions, including any errors in or discontinuance of disclosure regarding the methods or policies
relating to a Reference Asset. No investment advisor of a Reference Asset nor any Reference Asset Issuer is involved in the offerings
of the notes in any way and has no obligation to consider your interests as an owner of the notes in taking any actions relating to a
Reference Asset that might affect the value of the notes. Neither we nor any of our affiliates has independently verified the adequacy
or accuracy of the information about any investment advisor or any Reference Asset Issuer contained in any public disclosure of information.
You, as an investor in the notes, should make your own investigation into any Reference Asset Issuers.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B>The correlation between the performance of an ETF Reference Asset and the performance of the applicable Underlying Index may be
imperfect.</B> &mdash; The performance of each ETF Reference Asset is linked principally to the performance of the applicable Underlying
Index. However, because of the potential discrepancies identified in more detail in the product supplement, the return on an ETF Reference
Asset may correlate imperfectly with the return on the applicable Underlying Index.</TD></TR></TABLE>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="text-align: right; width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B>Any Reference Asset that is an ETF is subject to management risks. </B> &mdash; Any Reference Asset that is an ETF is subject to
management risk, which is the risk that the applicable investment advisor&rsquo;s investment strategy, the implementation of which is
subject to a number of constraints, may not produce the intended results. For example, the applicable investment advisor may invest a
portion of a Reference Asset Issuer&rsquo;s assets in securities not included in the relevant industry or sector but which the applicable
investment advisor believes will help the applicable Reference Asset track the relevant industry or sector.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B>You must rely on your own evaluation of the merits of an investment linked to the Reference Assets.</B> &mdash; In the ordinary
course of their businesses, our affiliates from time to time may express views on expected movements in the levels of the Reference Assets
or the prices of the securities held by or included in the Reference Assets. One or more of our affiliates have published, and in the
future may publish, research reports that express views on the Reference Assets or these securities. However, these views are subject
to change from time to time. Moreover, other professionals who deal in the markets relating to the Reference Assets at any time may have
significantly different views from those of our affiliates. You are encouraged to derive information concerning the Reference Assets from
multiple sources, and you should not rely on the views expressed by our affiliates. Neither the offering of the notes nor any views which
our affiliates from time to time may express in the ordinary course of their businesses constitutes a recommendation as to the merits
of an investment in the notes.</TD></TR></TABLE>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Risks Relating to the NASDAQ-100 Index<SUP>&reg;</SUP></B></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B>An investment in the notes is subject to risks associated with foreign securities markets. </B> &mdash; The NASDAQ-100 Index<SUP>&reg;</SUP>
tracks the value of certain foreign equity securities. You should be aware that investments in securities linked to the value of foreign
equity securities involve particular risks. The foreign securities markets comprising the NASDAQ-100 Index<SUP>&reg;</SUP> may have less liquidity
and may be more volatile than U.S. or other securities markets and market developments may affect foreign markets differently from U.S.
or other securities markets. Direct or indirect government intervention to stabilize these foreign securities markets, as well as cross-shareholdings
in foreign companies, may affect trading prices and volumes in these markets. Also, there is generally less publicly available information
about foreign companies than about those U.S. companies that are subject to the reporting requirements of the U.S. Securities and Exchange
Commission, and foreign companies are subject to accounting, auditing and financial reporting standards and requirements that differ from
those applicable to U.S. reporting companies.<BR STYLE="clear: right">
Prices of securities in foreign countries are subject to political, economic, financial and social factors that apply in those geographical
regions. These factors, which could negatively affect those securities markets, include the possibility of recent or future changes in
a foreign government&rsquo;s economic and fiscal policies, the possible imposition of, or changes in, currency exchange laws or other
laws or restrictions applicable to foreign companies or investments in foreign equity securities and the possibility of fluctuations in
the rate of exchange between currencies, the possibility of outbreaks of hostility and political instability and the possibility of natural
disaster or adverse public health developments in the region. Moreover, foreign economies may differ favorably or unfavorably from the
U.S. economy in important respects such as growth of gross national product, rate of inflation, capital reinvestment, resources and self-sufficiency.</TD></TR></TABLE>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Risks Related to the Financial Select Sector SPDR<SUP>&reg;</SUP> Fund</B></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B>An investment in the notes is subject to risks associated with foreign securities markets. </B> &mdash; All or substantially all
of the equity securities held by the Financial Select Sector SPDR<I><SUP>&reg;</SUP></I> Fund are issued by companies in the financial services sector.
The profitability of these companies is largely dependent on the availability and cost of capital, and can fluctuate significantly, particularly
when market interest rates change. Credit losses resulting from financial difficulties of these companies&rsquo; customers can negatively
impact the sector. In addition, adverse economic, business, or political developments could have a major effect on the value of the securities
held by the Financial Select Sector SPDR<I><SUP>&reg;</SUP></I> Fund. As a result of these factors, the value of the notes may be subject to greater
volatility and be more adversely affected by economic, political or regulatory events relating to the financial services sector.</TD></TR></TABLE>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Risks Related to the SPDR<SUP>&reg;</SUP> S&amp;P<SUP>&reg;</SUP> Biotech ETF</B></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B>An investment in the notes is subject to risks associated with concentration in the biotechnology sector.</B> &mdash; The stocks
held by the SPDR<SUP>&reg;</SUP>&nbsp;S&amp;P<SUP>&reg;</SUP>&nbsp;Biotech ETF are generally concentrated in the biotechnology industry.
Companies within the biotech industry invest heavily in research and development which may not necessarily lead to commercially successful
products. This industry is also subject to increased governmental regulation which may delay or inhibit the release of new products. Many
biotech companies are dependent upon their ability to use and enforce intellectual property rights and patents. Any impairment of such
rights may have adverse financial consequences. Biotech stocks, especially those of smaller, less-seasoned companies, tend to be more
volatile than the overall market. Biotech companies can be significantly affected by technological change and obsolescence, product liability
lawsuits and consequential high insurance costs.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B>An investment in the notes is subject to risks associated with investing in small-capitalization and mid-capitalization companies.
</B>&mdash; The SPDR<SUP>&reg;</SUP> S&amp;P<SUP>&reg;</SUP> Biotech ETF may invest in companies that may be considered small-capitalization or mid-capitalization
companies. These companies often have greater stock price volatility, lower trading volume and less liquidity than large-capitalization
companies and therefore the SPDR<SUP>&reg;</SUP> S&amp;P<SUP>&reg;</SUP> Biotech ETF&rsquo;s share price may be more volatile than an investment in stocks issued
by large-capitalization companies. Stock prices of small-capitalization or mid-capitalization companies are also more vulnerable than
those of large-capitalization companies to adverse business and economic developments, and the stocks of small-capitalization or mid-capitalization
companies may be thinly traded, making it difficult for the SPDR<SUP>&reg;</SUP> S&amp;P<SUP>&reg;</SUP> Biotech ETF to buy and sell them. In addition, small-capitalization
or mid-capitalization companies are typically less stable financially than large-capitalization companies and may depend on a small number
of key personnel, making them more vulnerable to loss of personnel. Small-capitalization or mid-capitalization companies are often subject
to less analyst coverage and may be in early, and less predictable, periods of their corporate existences. Such companies tend to have
smaller revenues, less diverse product lines, smaller shares of their product or service markets, fewer financial resources and less competitive
strengths than large-capitalization companies and are more susceptible to adverse developments related to their products.</TD></TR></TABLE>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="text-align: right; width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"><B>General Risk Factors</B></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B>Your investment is subject to the credit risk of Bank of Montreal.</B> &mdash; Our credit ratings and credit spreads may adversely
affect the market value of the notes. Investors are dependent on our ability to pay any amounts due on the notes, and therefore investors
are subject to our credit risk and to changes in the market&rsquo;s view of our creditworthiness. Any decline in our credit ratings or
increase in the credit spreads charged by the market for taking our credit risk is likely to adversely affect the value of the notes.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B>Potential conflicts.</B> &mdash; We and our affiliates play a variety of roles in connection with the issuance of the notes, including
acting as calculation agent. In performing these duties, the economic interests of the calculation agent and other affiliates of ours
are potentially adverse to your interests as an investor in the notes. We or one or more of our affiliates may also engage in trading
of shares of any Reference Asset that is an ETF or the securities held by or included in a Reference Asset on a regular basis as part
of our general broker-dealer and other businesses, for proprietary accounts, for other accounts under management or to facilitate transactions
for our customers. Any of these activities could adversely affect the level of the Reference Assets and, therefore, the market value of,
and the payments on, the notes. We or one or more of our affiliates may also issue or underwrite other securities or financial or derivative
instruments with returns linked or related to changes in the performance of the Reference Assets. By introducing competing products into
the marketplace in this manner, we or one or more of our affiliates could adversely affect the market value of the notes.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B>Our initial estimated value of the notes will be lower than the price to public.</B> &mdash; Our initial estimated value of the
notes is only an estimate, and is based on a number of factors. The price to public of the notes will exceed our initial estimated value,
because costs associated with offering, structuring and hedging the notes are included in the price to public, but are not included in
the estimated value. These costs include any underwriting discount and selling concessions, the profits that we and our affiliates expect
to realize for assuming the risks in hedging our obligations under the notes and the estimated cost of hedging these obligations. The
initial estimated value of the notes may be as low as the amount indicated on the cover page hereof.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B>Our initial estimated value does not represent any future value of the notes, and may also differ from the estimated value of any
other party.</B> &mdash; Our initial estimated value of the notes as of the date hereof is, and our estimated value as determined on the
Pricing Date will be, derived using our internal pricing models. This value is based on market conditions and other relevant factors,
which include volatility of the Reference Assets, dividend rates and interest rates. Different pricing models and assumptions could provide
values for the notes that are greater than or less than our initial estimated value. In addition, market conditions and other relevant
factors after the Pricing Date are expected to change, possibly rapidly, and our assumptions may prove to be incorrect. After the Pricing
Date, the value of the notes could change dramatically due to changes in market conditions, our creditworthiness, and the other factors
set forth herein and in the product supplement. These changes are likely to impact the price, if any, at which we or BMOCM would be willing
to purchase the notes from you in any secondary market transactions. Our initial estimated value does not represent a minimum price at
which we or our affiliates would be willing to buy your notes in any secondary market at any time.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B>The terms of the notes are not determined by reference to the credit spreads for our conventional fixed-rate debt. </B> &mdash;
To determine the terms of the notes, we will use an internal funding rate that represents a discount from the credit spreads for our conventional
fixed-rate debt. As a result, the terms of the notes are less favorable to you than if we had used a higher funding rate.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B>Certain costs are likely to adversely affect the value of the notes.</B> &mdash; Absent any changes in market conditions, any secondary
market prices of the notes will likely be lower than the price to public. This is because any secondary market prices will likely take
into account our then-current market credit spreads, and because any secondary market prices are likely to exclude all or a portion of
any underwriting discount and selling concessions, and the hedging profits and estimated hedging costs that are included in the price
to public of the notes and that may be reflected on your account statements. In addition, any such price is also likely to reflect a discount
to account for costs associated with establishing or unwinding any related hedge transaction, such as dealer discounts, mark-ups and other
transaction costs. As a result, the price, if any, at which BMOCM or any other party may be willing to purchase the notes from you in
secondary market transactions, if at all, will likely be lower than the price to public. Any sale that you make prior to the Maturity
Date could result in a substantial loss to you.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B>Lack of liquidity.</B> &mdash; The notes will not be listed on any securities exchange. BMOCM may offer to purchase the notes in
the secondary market, but is not required to do so. Even if there is a secondary market, it may not provide enough liquidity to allow
you to trade or sell the notes easily. Because other dealers are not likely to make a secondary market for the notes, the price at which
you may be able to trade the notes is likely to depend on the price, if any, at which BMOCM is willing to buy the notes.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B>Hedging and trading activities.</B> &mdash; We or any of our affiliates have carried out or may carry out hedging activities related
to the notes, including purchasing or selling shares of any Reference Assets that are ETFs or securities held by or included in the Reference
Assets, futures or options relating to the Reference Assets or securities held by or included in the Reference Assets or other derivative
instruments with returns linked or related to changes in the performance on the Reference Assets or securities held by or included in
the Reference Assets. We or our affiliates may also trade in any Reference Assets that are ETFs, such securities, or instruments related
to the Reference Assets or such securities from time to time. Any of these hedging or trading activities on or prior to the Pricing Date
and during the term of the notes could adversely affect the payments on the notes.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B>Many economic and market factors will influence the value of the notes.</B> &mdash; In addition to the levels of the Reference
Assets and interest rates on any trading day, the value of the notes will be affected by a number of economic and market factors that
may either offset or magnify each other, and which are described in more detail in the product supplement.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B>Significant aspects of the tax treatment of the notes are uncertain.</B> &mdash; The tax treatment of the notes is uncertain. We
do not plan to request a ruling from the Internal Revenue Service or from any Canadian authorities regarding the tax treatment of the
notes, and the Internal Revenue Service or a court may not agree with the tax treatment described herein.<BR STYLE="clear: right">
The Internal Revenue Service has released a notice that may affect the taxation of holders of &ldquo;prepaid forward contracts&rdquo;
and similar instruments. According to the notice, the Internal Revenue Service and the U.S. Treasury are actively considering whether
the holder of such instruments should be required to accrue ordinary income on a current basis. While it is not clear whether the notes
would be viewed as similar to such instruments, it is possible that any future guidance could materially and adversely affect the tax
consequences of an investment in the notes, possibly with retroactive effect.<BR STYLE="clear: right">
Please read carefully the section entitled &quot;U.S. Federal Tax Information&quot; herein, the section entitled &quot;Supplemental Tax
Considerations&ndash;Supplemental U.S. Federal Income Tax Considerations&quot; in the accompanying product supplement, the section entitled
&quot;United States Federal Income Taxation&quot; in the accompanying prospectus and the section entitled &quot;Certain Income Tax Consequences&quot;
in the accompanying prospectus supplement. You should consult your tax advisor about your own tax situation.</TD></TR></TABLE>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="text-align: right; width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Examples of the Hypothetical Payment at Maturity for a $1,000 Investment
in the Notes </B></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following table illustrates the hypothetical
payments on a note at maturity, assuming that the notes are not automatically redeemed. The hypothetical payments are based on a $1,000
investment in the note, a hypothetical Initial Level of 100.00, a hypothetical Trigger Level of 65.00 for each Reference Asset (65.00%
of the hypothetical Initial Level), a hypothetical Call Level of 100.00 (100.00% of the hypothetical Initial Level), a range of hypothetical
Final Levels and the effect on the payment at maturity if (i) a Trigger Event occurs or (ii) if a Trigger Event does not occur.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The hypothetical examples shown below are intended
to help you understand the terms of the notes. If the notes are not automatically redeemed, the actual cash amount that you will receive
at maturity will depend upon whether the closing level of the Reference Asset is less than its Trigger Level on any trading day during
the Monitoring Period and whether the Final Level of the Least Performing Reference Asset. If the notes are automatically redeemed prior
to maturity, the hypothetical examples below will not be relevant, and you will receive on the applicable Call Settlement Date, for each
$1,000 principal amount, the principal amount plus the applicable Contingent Coupon.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As discussed in more detail above, your total return
on the notes will also depend on the number of Contingent Coupon Dates on which the Contingent Coupon is payable. It is possible that
the only payments on your notes will be the payment, if any, due at maturity. The payment at maturity will not exceed the principal amount,
and may be significantly less.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 9pt">
  <TR STYLE="background-color: #BFBFBF">
    <TD STYLE="white-space: nowrap; width: 25%; border: Black 1pt solid; text-align: center"><B>Hypothetical Final Level of the <BR>
Least Performing Reference <BR>
Asset</B></TD>
    <TD STYLE="white-space: nowrap; width: 25%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><B>Hypothetical Final Level of the <BR>
Least Performing Reference <BR>
Asset Expressed as a Percentage <BR>
of its Initial Level </B></TD>
    <TD STYLE="white-space: nowrap; width: 25%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><B>Payment at Maturity Assuming a <BR>
Trigger Event Has Not Occurred <BR>
(Excluding Coupons)</B></TD>
    <TD STYLE="white-space: nowrap; width: 25%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><B>Payment at Maturity Assuming a <BR>
Trigger Event Has Occurred <BR>
(Excluding Coupons)</B></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center">200.00</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">200.00%</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">$1,000.00</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">$1,000.00</TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center">180.00</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">180.00%</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">$1,000.00</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">$1,000.00</TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center">160.00</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">160.00%</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">$1,000.00</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">$1,000.00</TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center">140.00</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">140.00%</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">$1,000.00</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">$1,000.00</TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center">120.00</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">120.00%</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">$1,000.00</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">$1,000.00</TD></TR>
  <TR STYLE="background-color: #BFBFBF">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center">100.00</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">100.00%</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">$1,000.00</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">$1,000.00</TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center">90.00</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">90.00%</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">$1,000.00</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">$900.00</TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center">80.00</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">80.00%</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">$1,000.00</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">$800.00</TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center">70.00</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">70.00%</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">$1,000.00</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">$700.00</TD></TR>
  <TR STYLE="background-color: #BFBFBF">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center">65.00</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">65.00%</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">$1,000.00</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">$650.00</TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center">64.99</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">64.99%</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">-</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">$649.99</TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center">60.00</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">60.00%</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">-</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">$600.00</TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center">40.00</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">40.00%</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">-</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">$400.00</TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center">20.00</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">20.00%</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">-</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">$200.00</TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center">0.00</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">0.00%</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">-</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">$0.00</TD></TR>
  </TABLE>
<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="text-align: right; width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"><B>U.S. Federal Tax Information</B></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">By purchasing the notes, each holder agrees (in
the absence of a change in law, an administrative determination or a judicial ruling to the contrary) to treat each note as a pre-paid
contingent income-bearing derivative contract for U.S. federal income tax purposes. In the opinion of our counsel, Mayer Brown LLP, it
would generally be reasonable to treat the notes as pre-paid contingent income-bearing derivative contracts in respect of the Reference
Assets for U.S. federal income tax purposes. However, the U.S. federal income tax consequences of your investment in the notes are uncertain
and the Internal Revenue Service could assert that the notes should be taxed in a manner that is different from that described in the
preceding sentence. Please see the discussion in the accompanying product supplement under &quot;Supplemental Tax Considerations&mdash;Supplemental
U.S. Federal Income Tax Considerations&mdash;Notes Treated as Investment Units Consisting of a Debt Portion and a Put Option, as Pre-Paid
Contingent Income-Bearing Derivative Contracts, or as Pre-Paid Derivative Contracts&mdash;Notes Treated as Pre-Paid Contingent Income-Bearing
Derivative Contracts,&quot; which applies to the notes.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="text-align: right; width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Supplemental Plan of Distribution (Conflicts of Interest)</B></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">BMOCM will purchase the notes from us at a purchase
price reflecting the commission set forth on the cover hereof. BMOCM has informed us that, as part of its distribution of the notes, it
will reoffer the notes to other dealers who will sell them. Each such dealer, or each additional dealer engaged by a dealer to whom BMOCM
reoffers the notes, will receive a commission from BMOCM, which will not exceed the commission set forth on the cover page. We or one
of our affiliates may also pay a referral fee to certain dealers in connection with the distribution of the notes.&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Certain dealers who purchase the notes for sale
to certain fee-based advisory accounts may forego some or all of their selling concessions, fees or commissions. The public offering price
for investors purchasing the notes in these accounts may be less than 100% of the principal amount, as set forth on the cover page of
this document. Investors that hold their notes in these accounts may be charged fees by the investment advisor or manager of that account
based on the amount of assets held in those accounts, including the notes.&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We will deliver the notes on a date that is greater
than one business day following the pricing date. Under Rule 15c6-1 of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange
Act&rdquo;), trades in the secondary market generally are required to settle in one business day, unless the parties to any such trade
expressly agree otherwise. Accordingly, purchasers who wish to trade the notes more than one business day prior to the issue date will
be required to specify alternative settlement arrangements to prevent a failed settlement.&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We own, directly or indirectly, all of the outstanding
equity securities of BMOCM, the agent for this offering. In accordance with FINRA Rule 5121, BMOCM may not make sales in this offering
to any of its discretionary accounts without the prior written approval of the customer.&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We reserve the right to withdraw, cancel or modify
the offering of the notes and to reject orders in whole or in part. You may cancel any order for the notes prior to its acceptance.&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">You should not construe the offering of the notes
as a recommendation of the merits of acquiring an investment linked to the Reference Assets or as to the suitability of an investment
in the notes.&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">BMOCM may, but is not obligated to, make a market
in the notes. BMOCM will determine any secondary market prices that it is prepared to offer in its sole discretion.&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">We may use the final pricing supplement relating to the notes in the
initial sale of the notes. In addition, BMOCM or another of our affiliates may use the final pricing supplement in market-making transactions
in any notes after their initial sale. Unless BMOCM or we inform you otherwise in the confirmation of sale, the final pricing supplement
is being used by BMOCM in a market-making transaction.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For a period of approximately three months following
issuance of the notes, the price, if any, at which we or our affiliates would be willing to buy the notes from investors, and the value
that BMOCM may also publish for the notes through one or more financial information vendors and which could be indicated for the notes
on any brokerage account statements, will reflect a temporary upward adjustment from our estimated value of the notes that would otherwise
be determined and applicable at that time. This temporary upward adjustment represents a portion of (a) the hedging profit that we or
our affiliates expect to realize over the term of the notes and (b) any underwriting discount and the selling concessions paid in connection
with this offering. The amount of this temporary upward adjustment will decline to zero on a straight-line basis over the three-month
period.&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The notes and the related offer to purchase notes
and sale of notes under the terms and conditions provided herein do not constitute a public offering in any non-U.S. jurisdiction, and
are being made available only to individually identified investors pursuant to a private offering as permitted in the relevant jurisdiction.
The notes are not, and will not be, registered with any securities exchange or registry located outside of the United States and have
not been registered with any non-U.S. securities or banking regulatory authority. The contents of this document have not been reviewed
or approved by any non-U.S. securities or banking regulatory authority. Any person who wishes to acquire the notes from outside the United
States should seek the advice or legal counsel as to the relevant requirements to acquire these notes.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>British Virgin Islands.</I> The notes have not
been, and will not be, registered under the laws and regulations of the British Virgin Islands, nor has any regulatory authority in the
British Virgin Islands passed comment upon or approved the accuracy or adequacy of this document. This pricing supplement and the related
documents shall not constitute an offer, invitation or solicitation to any member of the public in the British Virgin Islands for the
purposes of the Securities and Investment Business Act, 2010, of the British Virgin Islands.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Cayman Islands.</I> Pursuant to the Companies
Law (as amended) of the Cayman Islands, no invitation may be made to the public in the Cayman Islands to subscribe for the notes by or
on behalf of the issuer unless at the time of such invitation the issuer is listed on the Cayman Islands Stock Exchange. The issuer is
not presently listed on the Cayman Islands Stock Exchange and, accordingly, no invitation to the public in the Cayman Islands is to be
made by the issuer (or by any dealer on its behalf). No such invitation is made to the public in the Cayman Islands hereby.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Dominican Republic.</I> Nothing in this pricing
supplement constitutes an offer of securities for sale in the Dominican Republic. The notes have not been, and will not be, registered
with the Superintendence of Securities Market of the Dominican Republic (Superintendencia del Mercado de Valores), under Dominican Securities
Market Law No. 249-17 (&ldquo;Securities Law 249-17&rdquo;), and the notes may not be offered or sold within the Dominican Republic or
to, or for the account or benefit of, Dominican persons (as defined under Securities Law 249-17 and its regulations). Failure to comply
with these directives may result in a violation of Securities Law 249-17 and its regulations.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Israel.</I> This pricing supplement is intended
solely for investors listed in the First Supplement of the Israeli Securities Law of 1968, as amended. A prospectus has not been prepared
or filed, and will not be prepared or filed, in Israel relating to the notes offered hereunder. The notes cannot be resold in Israel other
than to investors listed in the First Supplement of the Israeli Securities Law of 1968, as amended.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="text-align: right; width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">No action will be taken in Israel that would permit
an offering of the notes or the distribution of any offering document or any other material to the public in Israel. In particular, no
offering document or other material has been reviewed or approved by the Israel Securities Authority. Any material provided to an offeree
in Israel may not be reproduced or used for any other purpose, nor be furnished to any other person other than those to whom copies have
been provided directly by us or the selling agents.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Nothing in this pricing supplement or any other
offering material relating to the notes, should be considered as the rendering of a recommendation or advice, including investment advice
or investment marketing under the Law For Regulation of Investment Advice, Investment Marketing and Investment Portfolio Management, 1995,
to purchase any note. The purchase of any note will be based on an investor&rsquo;s own understanding, for the investor&rsquo;s own benefit
and for the investor&rsquo;s own account and not with the aim or intention of distributing or offering to other parties. In purchasing
the notes, each investor declares that it has the knowledge, expertise and experience in financial and business matters so as to be capable
of evaluating the risks and merits of an investment in the notes, without relying on any of the materials provided.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Mexico.</I> The notes have not been registered
with the National Registry of Securities maintained by the Mexican National Banking and Securities Commission and may not be offered or
sold publicly in Mexico. This pricing supplement and the related documents may not be publicly distributed in Mexico. The notes may only
be offered in a private offering pursuant to Article 8 of the Securities Market Law.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Switzerland.</I> This pricing supplement is not
intended to constitute an offer or solicitation to purchase or invest in any notes. Neither this pricing supplement nor any other offering
or marketing material relating to the notes constitutes a prospectus compliant with the requirements of articles 35 et seq. of the Swiss
Financial Services Act (&quot;FinSA&quot;)) for a public offering of the notes in Switzerland and no such prospectus has been or will
be prepared for or in connection with the offering of the notes in Switzerland.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Neither this pricing supplement nor any other offering
or marketing material relating to the notes has been or will be filed with or approved by a Swiss review body (Pr&uuml;fstelle). No application
has been or is intended to be made to admit the notes to trading on any trading venue (SIX Swiss Exchange or on any other exchange or
any multilateral trading facility) in Switzerland. Neither this pricing supplement nor any other offering or marketing material relating
to the notes may be publicly distributed or otherwise made publicly available in Switzerland.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The notes may not be publicly offered, directly
or indirectly, in Switzerland within the meaning of FinSA except (i) in any circumstances falling within the exemptions to prepare a prospectus
listed in article 36 para. 1 FinSA or (ii) where such offer does not qualify as a public offer in Switzerland, provided always that no
offer of notes shall require the Issuer or any offeror to publish a prospectus pursuant to article 35 FinSA in respect to such offer and
that such offer shall comply with the additional restrictions set out below (if applicable). The Issuer has not authorised and does not
authorise any offer of notes which would require the Issuer or any offeror to publish a prospectus pursuant to article 35 FinSA in respect
of such offer. For purposes of this provision &quot;public offer&quot; shall have the meaning as such term is understood pursuant to article
3 lit. g and h FinSA and the Swiss Financial Services Ordinance (&quot;FinSO&quot;).</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The notes do not constitute participations in a
collective investment scheme within the meaning of the Swiss Collective Investment Schemes Act. They are not subject to the approval of,
or supervision by, the Swiss Financial Market Supervisory Authority (&quot;FINMA&quot;), and investors in the notes will not benefit from
protection under CISA or supervision by FINMA.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Prohibition of Offer to Private Clients in Switzerland
- No Key Information Document pursuant to article 58 FinSA (Basisinformationsblatt f&uuml;r Finanzinstrumente) or equivalent document
under foreign law pursuant to article 59 para. 2 FinSA has been or will be prepared in relation to the notes. Therefore, the following
additional restriction applies: Notes qualifying as &quot;debt securities with a derivative character&quot; pursuant to article 86 para.
2 FinSO may not be offered within the meaning of article 58 para. 1 FinSA, and neither this pricing supplement nor any other offering
or marketing material relating to such notes may be made available, to any retail client (Privatkunde) within the meaning of FinSA in
Switzerland.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The notes may also be sold in the following jurisdictions,
provided, in each case, any sales are made in accordance with all applicable laws in such jurisdiction:</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Barbados</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Bermuda</TD></TR></TABLE>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="text-align: right; width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Additional Information Relating to the Estimated Initial Value of
the Notes</B></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our estimated initial value of the notes on the
date hereof, and that will be set forth on the cover page of the final pricing supplement relating to the notes, equals the sum of the
values of the following hypothetical components:</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>a fixed-income debt component with the same tenor as the notes, valued using our internal funding rate for structured notes; and&nbsp;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>one or more derivative transactions relating to the economic terms of the notes.&nbsp;</TD></TR></TABLE>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The internal funding rate used in the determination
of the initial estimated value generally represents a discount from the credit spreads for our conventional fixed-rate debt. The value
of these derivative transactions is derived from our internal pricing models. These models are based on factors such as the traded market
prices of comparable derivative instruments and on other inputs, which include volatility, dividend rates, interest rates and other factors.
As a result, the estimated initial value of the notes on the Pricing Date will be determined based on the market conditions on the Pricing
Date.&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="text-align: right; width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"><B>The Reference Assets</B></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">All disclosures contained in this pricing supplement
regarding the Reference Assets, including, without limitation, their make-up, method of calculation, and changes in their components and
their historical closing levels, have been derived from publicly available information prepared by the applicable sponsors. The information
reflects the policies of, and is subject to change by, the sponsors. The sponsors own the copyrights and all rights to the Reference Assets.
The sponsors are under no obligation to continue to publish, and may discontinue publication of, the Reference Assets. Neither we nor
BMOCM accepts any responsibility for the calculation, maintenance or publication of any Reference Asset or any successor.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Information provided to or filed with the SEC under
the Exchange Act and the Investment Company Act of 1940 relating to any Reference Asset that is an ETF may be obtained through the SEC&rsquo;s
website at http://www.sec.gov.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We encourage you to review recent levels of the
Reference Assets prior to making an investment decision with respect to the notes.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"><B>The NASDAQ-100 Index<SUP>&reg;</SUP> (&ldquo;NDX&rdquo;)</B></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The NASDAQ-100 Index<SUP>&reg;</SUP> is a modified market capitalization-weighted
index of 100 of the largest stocks of both U.S. and non-U.S. non-financial companies listed on The NASDAQ Stock Market based on market
capitalization. It does not contain securities of financial companies, including investment companies. The NASDAQ-100 Index<SUP>&reg;</SUP> which
includes companies across a variety of major industry groups, was launched on January 31, 1985, with a base index value of 250.00. On
January 1, 1994, the base index value was reset to 125.00. The NASDAQ-100 Index<SUP>&reg;</SUP> composition is reviewed on an annual basis in December.
Nasdaq, Inc. publishes the NASDAQ-100 Index<SUP>&reg;</SUP>. Current information regarding the market value of the Nasdaq-100 Index<SUP>&reg;</SUP> is available
from Nasdaq, Inc. as well as numerous market information services.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The share weights of the component securities of
the Nasdaq-100 Index<SUP>&reg;</SUP> at any time are based upon the total shares outstanding in each of those securities and are additionally subject,
in certain cases, to rebalancing. Accordingly, each underlying stock&rsquo;s influence on the level of the NASDAQ-100 Index<SUP>&reg;</SUP> is directly
proportional to the value of its share weight.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Index Calculation</I></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">At any moment in time, the level of the NASDAQ-100
Index<SUP>&reg;</SUP> equals the aggregate value of the then-current share weights of each of the component securities, which are based on the total
shares outstanding of each such component security, multiplied by each such security&rsquo;s respective last sale price on The NASDAQ
Stock Market (which may be the official closing price published by The NASDAQ Stock Market), and divided by a scaling factor (the &ldquo;divisor&rdquo;),
which becomes the basis for the reported level of the NASDAQ-100 Index<SUP>&reg;</SUP>. The divisor serves the purpose of scaling such aggregate
value to a lower order of magnitude, which is more desirable for reporting purposes.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Underlying Stock Eligibility Criteria and Annual Ranking Review</I></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">Initial Eligibility Criteria</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">To be eligible for initial inclusion in the NASDAQ-100
Index<SUP>&reg;</SUP>, a security must be listed on The NASDAQ Stock Market and meet the following criteria:</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the security&rsquo;s U.S. listing must be exclusively on the NASDAQ Global Select Market or the NASDAQ Global Market;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the security must be issued by a non-financial company (any industry other than financials) according to the Industry Classification
Benchmark (ICB);</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the security may not be issued by an issuer currently in bankruptcy proceedings;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the security must generally be a common stocks, ordinary shares, American Depositary Receipts (ADRs), or tracking stock (closed-end
funds, convertible debentures, exchange traded funds, limited liability companies, limited partnership interests, preferred stocks, rights,
shares or units of beneficial interests, warrants, units and other derivative securities are not included in the NASDAQ-100 Index<SUP>&reg;</SUP>,
nor are the securities of investment companies). Companies organized as Real Estate Investment Trusts (&ldquo;REITs&rdquo;) are not eligible
for index inclusion. If the security is a depositary receipt representing a security of a non-U.S. issuer, then references to the &quot;issuer&quot;
are references to the underlying security and the total shares outstanding (&ldquo;TSO&rdquo;) is the actual depositary shares outstanding
as reported by the depositary banks;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the security must have a three-month average daily trading volume of at least 200,000 shares;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>if the security is issued by an issuer organized under the laws of a jurisdiction outside the United States, it must have listed options
on a recognized market in the United States or be eligible for listed-options trading on a recognized options market in the United States;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the issuer of the security may not have entered into a definitive agreement or other arrangement that would make it ineligible for
index inclusion and where the transaction is imminent as determined by the Index Management Committee;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the issuer of the security may not have annual financial statements with an audit opinion that is currently withdrawn; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the issuer of the security must have &ldquo;seasoned&rdquo; on the NASDAQ Stock Market or another recognized market (generally, a
company is considered to be seasoned if it has been listed on a market for at least three full months, excluding the first month of initial
listing).</TD></TR></TABLE>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">Continued Eligibility Criteria</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In addition, to be eligible for continued inclusion
in the NASDAQ-100 Index<SUP>&reg;</SUP> the following criteria apply:</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the security&rsquo;s U.S. listing must be exclusively on the NASDAQ Global Select Market or the NASDAQ Global Market;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the security must be issued by a non-financial company;</TD></TR></TABLE>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="text-align: right; width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the security may not be issued by an issuer currently in bankruptcy proceedings;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the security must have an average daily trading volume of at least 200,000 shares in the previous three-month trading period as measured
annually during the ranking review process described below;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>if the issuer of the security is organized under the laws of a jurisdiction outside the United States, then such security must have
listed options on a recognized market in the United States or be eligible for listed-options trading on a recognized options market in
the United States, as measured annually during the ranking review process;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the issuer of the security may not have entered into a definitive agreement or other arrangement that would likely result in the security
no longer being eligible;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the security must have an adjusted market capitalization equal to or exceeding 0.10% of the aggregate adjusted market capitalization
of the NASDAQ-100 Index<SUP>&reg;</SUP> at each month-end. In the event that a company does not meet this criterion for two consecutive month-ends,
it will be removed from the NASDAQ-100 Index<SUP>&reg;</SUP> effective after the close of trading on the third Friday of the following month; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the issuer of the security may not have annual financial statements with an audit opinion that is currently withdrawn.</TD></TR></TABLE>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">These eligibility criteria may be revised from time to time by Nasdaq,
Inc. without regard to the notes.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Annual Ranking Review</I></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The component securities are evaluated on an annual
basis (the &ldquo;Ranking Review&rdquo;), except under extraordinary circumstances, which may result in an interim evaluation, as follows.
Securities that meet the applicable eligibility criteria are ranked by market value. Eligible securities that are already in the NASDAQ-100
Index<SUP>&reg;</SUP> and that are ranked in the top 100 eligible securities (based on market capitalization) are retained in the NASDAQ-100 Index<SUP>&reg;</SUP>.
A security that is ranked 101 to 125 is also retained, provided that such security was ranked in the top 100 eligible securities as of
the previous Ranking Review or was added to the NASDAQ-100 Index<SUP>&reg;</SUP> subsequent to the previous Ranking Review. Securities not meeting
such criteria are replaced. The replacement securities chosen are those eligible securities not currently in the NASDAQ-100 Index<SUP>&reg;</SUP>
that have the largest market capitalization. The data used in the ranking includes end of October market data and is updated for total
shares outstanding submitted in a publicly filed SEC document via EDGAR through the end of November.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Replacements are made effective after the close
of trading on the third Friday in December. Moreover, if at any time during the year other than the Ranking Review, a component security
is determined by NASDAQ OMX to become ineligible for continued inclusion in the NASDAQ-100 Index<SUP>&reg;</SUP>, the security will be replaced with
the largest market capitalization security meeting the eligibility criteria listed above and not currently included in the NASDAQ-100
Index<SUP>&reg;</SUP>. Issuers that are added as a result of a spin-off are not replaced until after they have been included in a reconstitution.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Index Maintenance</I></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In addition to the Ranking Review, the securities
NASDAQ-100 Index<SUP>&reg;</SUP> are monitored every day by Nasdaq, Inc. with respect to changes in total shares outstanding arising from corporate
events, such as stock dividends, stock splits and certain spin-offs and rights issuances. Nasdaq, Inc. has adopted the following quarterly
scheduled weight adjustment procedures with respect to those changes. If the change in total shares outstanding arising from a corporate
action is greater than or equal to 10%, that change will be made to the NASDAQ-100 Index<SUP>&reg;</SUP> as soon as practical, normally within ten
days of such corporate action. Otherwise, if the change in total shares outstanding is less than 10%, then all such changes are accumulated
and made effective at one time on a quarterly basis after the close of trading on the third Friday in each of March, June, September and
December.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In either case, the share weights for those component
securities are adjusted by the same percentage amount by which the total shares outstanding have changed in those securities. Ordinarily,
whenever there is a change in the share weights, a change in a component security, or a change to the price of a component security due
to spin-off, rights issuances or special cash dividends, Nasdaq, Inc. adjusts the divisor to ensure that there is no discontinuity in
the level of the NASDAQ-100 Index<SUP>&reg;</SUP> that might otherwise be caused by any of those changes. All changes will be announced in advance.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Index Rebalancing</I></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Under the methodology employed, on a quarterly basis
coinciding with Nasdaq, Inc.&rsquo;s quarterly scheduled weight adjustment procedures, the component securities are categorized as either
&ldquo;Large Stocks&rdquo; or &ldquo;Small Stocks&rdquo; depending on whether their current percentage weights (after taking into account
scheduled weight adjustments due to stock repurchases, secondary offerings or other corporate actions) are greater than, or less than
or equal to, the average percentage weight in the NASDAQ-100 Index<SUP>&reg;</SUP> (i.e., as a 100-stock index, the average percentage weight in
the NASDAQ-100 Index<SUP>&reg;</SUP> is 1%).</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This quarterly examination will result in an index
rebalancing if it is determined that: (1) the current weight of the single largest market capitalization component security is greater
than 24% or (2) the &ldquo;collective weight&rdquo; of those component securities, the individual current weights of which are in excess
of 4.5%, when added together, exceed 48%. In addition, Nasdaq, Inc. may conduct a special rebalancing at any time if it is determined
to be necessary to maintain the integrity of the NASDAQ-100 Index<SUP>&reg;</SUP>.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If either one or both of these weight distribution
requirements are met upon quarterly review, or Nasdaq, Inc. determines that a special rebalancing is required, a weight rebalancing will
be performed. First, relating to weight distribution requirement (1) above, if the current weight of the single largest component security
exceeds 24%, then the weights of all Large Stocks will be scaled down proportionately towards 1% by enough of an amount for the adjusted
weight of the single largest component security to be set to 20%. Second, relating to weight distribution requirement (2) above, for those
component securities whose individual current weights or adjusted weights in accordance with the preceding step are in excess of 4.5%,
if their &ldquo;collective weight&rdquo; exceeds 48%, then the weights of all Large Stocks will be scaled down proportionately towards
1% by just enough amount for the &ldquo;collective weight,&rdquo; so adjusted, to be set to 40%.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="text-align: right; width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The aggregate weight reduction among the Large Stocks
resulting from either or both of the above rescalings will then be redistributed to the Small Stocks in the following iterative manner.
In the first iteration, the weight of the largest Small Stock will be scaled upwards by a factor which sets it equal to the average Index
weight of 1.0%. The weights of each of the smaller remaining Small Stocks will be scaled up by the same factor, reduced in relation to
each stock&rsquo;s relative ranking among the Small Stocks, such that the smaller the component security in the ranking, the less the
scale-up of its weight. This is intended to reduce the market impact of the weight rebalancing on the smallest component securities in
the NASDAQ-100 Index<SUP>&reg;</SUP>.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In the second iteration, the weight of the second
largest Small Stock, already adjusted in the first iteration, will be scaled upwards by a factor which sets it equal to the average index
weight of 1%. The weights of each of the smaller remaining Small Stocks will be scaled up by this same factor, reduced in relation to
each stock&rsquo;s relative ranking among the Small Stocks, such that, once again, the smaller the component stock in the ranking, the
less the scale-up of its weight.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Additional iterations will be performed until the
accumulated increase in weight among the Small Stocks exactly equals the aggregate weight reduction among the Large Stocks from rebalancing
in accordance with weight distribution requirement (1) and/or weight distribution requirement (2).</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Then, to complete the rebalancing procedure, once
the final percent weights of each of the component securities are set, the share weights will be determined anew based upon the last sale
prices and aggregate capitalization of the NASDAQ-100 Index<SUP>&reg;</SUP> at the close of trading on the last day in February, May, August and
November. Changes to the share weights will be made effective after the close of trading on the third Friday in March, June, September
and December, and an adjustment to the divisor will be made to ensure continuity of the NASDAQ-100 Index<SUP>&reg;</SUP>.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Ordinarily, new rebalanced weights will be determined
by applying the above procedures to the current share weights. However, Nasdaq, Inc. may from time to time determine rebalanced weights,
if necessary, by instead applying the above procedure to the actual current market capitalization of the component securities. In those
instances, Nasdaq, Inc. would announce the different basis for rebalancing prior to its implementation.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"><I>License Agreement</I></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The notes are not sponsored, endorsed, sold or promoted
by Nasdaq, Inc. or its affiliates (NASDAQ, with its affiliates, are referred to as the &ldquo;Corporations&rdquo;). The Corporations have
not passed on the legality or suitability of, or the accuracy or adequacy of descriptions and disclosures relating to, the notes. The
Corporations make no representation or warranty, express or implied to the owners of the notes or any member of the public regarding the
advisability of investing in securities generally or in the notes particularly, or the ability of the NASDAQ-100 Index<SUP>&reg;</SUP> to track general
stock market performance. The Corporations' only relationship to the Issuer (&ldquo;Licensee&rdquo;) is in the licensing of the Nasdaq<SUP>&reg;</SUP>,
the NASDAQ-100 Index<SUP>&reg;</SUP>, and certain trade names of the Corporations and the use of the NASDAQ-100 Index<SUP>&reg;</SUP> which is determined, composed
and calculated by NASDAQ without regard to Licensee or the notes. NASDAQ has no obligation to take the needs of the Licensee or the owners
of the notes into consideration in determining, composing or calculating the NASDAQ-100 Index<SUP>&reg;</SUP>. The Corporations are not responsible
for and have not participated in the determination of the timing of, prices at, or quantities of the notes to be issued or in the determination
or calculation of the equation by which the notes are to be converted into cash. The Corporations have no liability in connection with
the administration, marketing or trading of the notes.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>THE CORPORATIONS DO NOT GUARANTEE THE ACCURACY
AND/OR UNINTERRUPTED CALCULATION OF NASDAQ-100 Index<SUP>&reg;</SUP> OR ANY DATA INCLUDED THEREIN, THE CORPORATIONS MAKE NO WARRANTY, EXPRESS OR
IMPLIED, AS TO RESULTS TO BE OBTAINED BY LICENSEE, OWNERS OF THE NOTES, OR ANY OTHER PERSON OR ENTITY FROM THE USE OF THE NASDAQ-100 Index<SUP>&reg;</SUP>
OR ANY DATA INCLUDED THEREIN. THE CORPORATIONS MAKE NO EXPRESS OR IMPLIED WARRANTIES, AND EXPRESSLY DISCLAIM ALL WARRANTIES OF MERCHANTABILITY
OR FITNESS FOR A PARTICULAR PURPOSE OR USE WITH RESPECT TO THE NASDAQ-100 Index<SUP>&reg;</SUP> OR ANY DATA INCLUDED THEREIN. WITHOUT LIMITING ANY
OF THE FOREGOING, IN NO EVENT SHALL THE CORPORATIONS HAVE ANY LIABILITY FOR ANY LOST PROFITS OR SPECIAL, INCIDENTAL, PUNITIVE, INDIRECT,
OR CONSEQUENTIAL DAMAGES, EVEN IF NOTIFIED OF THE POSSIBILITY OF SUCH DAMAGES.</B></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"><B>The Financial Select Sector SPDR<SUP>&reg;</SUP> Fund (&ldquo;XLF&rdquo;)</B></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Financial Select Sector SPDR<SUP>&reg;</SUP> Fund (the
&ldquo;XLF&rdquo;) is an investment portfolio managed by SSgA Funds Management, Inc. (&ldquo;SSFM&rdquo;), the investment adviser to the
XLF. The XLF is an exchange-traded fund that trades on the NYSE Arca, Inc. (&ldquo;NYSE Arca&rdquo;) under the ticker symbol &ldquo;XLF.&rdquo;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Information provided to or filed with the SEC by
the Select Sector SPDR<SUP>&reg;</SUP> Trust pursuant to the Securities Act and the Investment Company Act can be located by reference
to SEC file numbers 333-57791 and 811-08837, respectively, through the SEC&rsquo;s website at http://www.sec.gov.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Investment Objective</I></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The XLF seeks to provide investment results that
correspond generally to the price and yield performance, before fees and expenses, of publicly traded equity securities of companies in
the financial sector, as represented by the Financial Select Sector Index (the &ldquo;IXM&rdquo;). The IXM measures the performance of
the financial sector of the U.S. equity market and includes companies in the following industries: diversified financial services; insurance;
banks; capital markets; mortgage real estate investment trusts (&ldquo;REITS&rdquo;); consumer finance; and thrifts and mortgage finance.
The returns of the XLF may be affected by certain management fees and other expenses, which are detailed in its prospectus.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Investment Strategy &mdash; Replication</I></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="text-align: right; width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The XLF pursues the indexing strategy of &ldquo;replication&rdquo;
in attempting to approximate the performance of IXM. The XLF will generally invest in substantially all of the equity securities included
in the IXM in approximately the same proportions as the IXM. There may, however, be instances where SSFM may choose to overweight another
stock in the IXM, purchase securities not included in the IXM that SSFM believes are appropriate to substitute for a security included
in the IXM or utilize various combinations of other available investment techniques in seeking to track accurately the IXM. The XLF will
normally invest at least 95% of its total assets in common stocks that comprise the IXM. The XLF may invest its remaining assets in money
market instruments (including repurchase contracts). Options and futures contracts (and convertible securities and structured notes) may
be used by the XLF in seeking performance that corresponds to the IXM and managing cash flows. SSFM anticipates that, under normal circumstances,
it may take several business days for additions and deletions to the S&amp;P 500<SUP>&reg;</SUP> Index (&ldquo;SPX&rdquo;) to be reflected in the
portfolio composition of the XLF. The Board of Trustees of the Select Sector SPDR<SUP>&reg;</SUP> Trust may change the XLF&rsquo;s investment
strategy and other policies without shareholder approval.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Correlation</I></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The IXM is a theoretical financial calculation,
while the&nbsp;XLF&nbsp;is an actual investment portfolio. The performance of the&nbsp;XLF&nbsp;and the IXM will vary somewhat due to
transaction costs, asset valuations, market impact, corporate actions (such as mergers and spin-offs) and timing variances. A figure of
100% would indicate perfect correlation. Any correlation of less than 100% is called &ldquo;tracking error.&rdquo; The&nbsp;XLF, using
a replication strategy, can be expected to have a lesser tracking error than a fund using representative sampling strategy. Representative
sampling is a strategy in which a fund invests in a representative sample of securities in a tracking index.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>The Financial Select Sector Index</I></B></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The IXM is a modified market capitalization-based
index, intended to provide an indication of the pattern of common stock price movements of companies that are components of the SPX and
are involved in the financial industry. The IXM is one of the nine Select Sector sub-indices of the SPX, each of which we refer to as
a &ldquo;Select Sector Index.&rdquo;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Index is also sponsored and compiled by S&amp;P
DJI. S&amp;P DJI determines the composition of the Index and relative weightings of the securities in the Index based on the Index methodology
(as the &ldquo;Index Compilation Agent&rdquo;). S&amp;P DJI also publishes information regarding the market value of the Index (as the
&ldquo;Index Provider&rdquo;). S&amp;P DJI is not affiliated with the Fund or the Adviser. The composition and weighting of the stocks
included in the IXM will likely differ from the composition and weighting of stocks included in any similar Select Sector Index that is
published and disseminated by S&amp;P. S&amp;P&rsquo;s only relationship to the Index Compilation Agent is the licensing of certain trademarks
and trade names of S&amp;P and of the SPX which is determined, composed and calculated by S&amp;P without regard to the Index Compilation
Agent.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>The Select Sector Indices </I></B></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Construction, Maintenance and Calculation of
The Select Sector Indices:</I></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Select Sector Index is developed and maintained
in accordance with the following criteria:</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Each of the component stocks in a Select Sector Index (the &ldquo;Component Stocks&rdquo;) has been selected from the universe of
companies defined by the SPX.</TD></TR></TABLE>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Each stock in the SPX is allocated to one and only one of the Select Sector Indices.</TD></TR></TABLE>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>The Index Compilation Agent assigns each constituent stock of the S&amp;P 500 Index to a Select Sector Index based on the Global Industry
Classification Standard (&ldquo;GICS&rdquo;). S&amp;P DJI has sole control over the removal of stocks from the S&amp;P 500 and the selection
of replacement stocks to be added to the S&amp;P 500.</TD></TR></TABLE>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Each Select Sector Index is calculated using a base-weighted aggregate methodology; that means the level of the Select Sector Index
reflects the total market value of all of its Component Stocks relative to a particular base period. Statisticians refer to this type
of index, one with a set of combined variables (such as price and number of shares), as a composite index.</TD></TR></TABLE>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Each Select Sector Index is calculated using the same methodology utilized by S&amp;P DJI in calculating the SPX, using a base-weighted
aggregate methodology. The daily calculation of each Select Sector Index is computed by dividing the total market value of the companies
in the Select Sector Index by a number called the &ldquo;Index Divisor.&rdquo;</TD></TR></TABLE>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Each Select Sector Index is weighted, on a quarterly basis, based on the float-adjusted market capitalization of each of the Component
Stocks, subject to the following asset diversification requirements: (i) the market capitalization-based weighted value of any single
Component Stock measured with prices as of the reference date and membership, shares outstanding and investable weight factors as of the
rebalancing effective date may not exceed 25% of the total value of its respective Select Sector Index; and (ii) the sum of the constituent
stocks with weight greater than 4.8% cannot exceed 50% of the total Index weight.</TD></TR></TABLE>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="text-align: right; width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Rebalancing the Select Sector Indices to meet the asset diversification requirements will be the responsibility of S&amp;P. If on
the second Friday of any calendar quarter-end month (a &ldquo;Quarterly Qualification Date&rdquo;), a Component Stock (or two or more
Component Stocks) approaches the maximum allowable value limits set forth above (the &ldquo;Asset Diversification Limits&rdquo;), the
percentage that such Component Stock (or Component Stocks) represents in the Select Sector Index will be reduced and the market capitalization-based
weighted value of such Component Stock (or Component Stocks) will be redistributed across the Component Stocks that do not closely approach
the Asset Diversification Limits in accordance with the following methodology: First, each Component Stock that exceeds 24% of the total
value of the Select Sector Index will be reduced to 23% of the total value of the Select Sector Index and the excess amount will be redistributed
proportionally across the remaining Component Stocks that each represent less than 23% of the total value of the Select Sector Index.
If as a result of this redistribution, another Component Stock then exceeds 23%, the redistribution will be repeated as necessary until
no company breaches the 23% weight cap. Second, if the sum of Component Stocks that each exceed 4.8% of the total value of the Select
Sector Index exceeds 50% of the total value of the Index, the Component Stocks will be ranked in descending order of their float-adjusted
market capitalization, and the first Component Stock to cause the 50% limit to be breached will be reduced to 4.5% and the excess amount
will be distributed proportionally across all remaining Component Stocks that represent less than 4.5% of the total value of the Select
Sector Index. This redistribution process will be repeated as necessary until at least 50% of the value of the Select Sector Index is
accounted for by Component Stocks representing no more than 4.8% of the total value of the Select Sector Index. If necessary, this reallocation
process may take place more than once to ensure that the Select Sector Index and the Select Sector SPDR Fund portfolio based upon it conform
to the requirements for qualification of the Select Sector SPDR Fund as a regulated investment company (&ldquo;RIC&rdquo;), under the
Internal Revenue Code of 1986, as amended (the &ldquo;Internal Revenue Code&rdquo;).</TD></TR></TABLE>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This occurs at the closing prices of the second
Friday of March, June, September and December and becomes effective after the market close on the third Friday of March, June, September
and December.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If, on the second to last business day of March,
June, September, or December a company has a weight greater than 24% or the sum of the companies with weights greater than 4.8% exceeds
50%, a secondary rebalancing will be triggered with the rebalancing effective date being after the close of the last business day of the
month. This secondary rebalancing will use the closing prices as of the second to last business day of March, June, September, or December,
and membership, shares outstanding, and investable weight factors as of the rebalancing effective date.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Index Compilation Agent at any time may determine
that a Component Stock which has been assigned to one Select Sector Index has undergone such a transformation in the composition of its
business that it should be removed from that Select Sector Index and assigned to a different Select Sector Index. In the event that the
Index Compilation Agent notifies the index calculation agent that a Component Stock&rsquo;s Select Sector Index assignment should be changed,
the index calculation agent will disseminate notice of the change following its standard procedure for announcing index changes and will
implement the change in the affected Select Sector Indices on a date no less than one week after the initial dissemination of information
on the sector change to the maximum extent practicable. It is not anticipated that Component Stocks will change sectors frequently. Component
Stocks removed from and added to the SPX will be deleted from and added to the appropriate Select Sector Index on the same schedule used
by S&amp;P for additions and deletions from the SPX insofar as practicable.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"><B>The SPDR<SUP>&reg;</SUP> S&amp;P<SUP>&reg;</SUP> Biotech ETF (&ldquo;XBI&rdquo;)</B></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">The SPDR<SUP>&reg;</SUP> S&amp;P<SUP>&reg;</SUP> Biotech ETF is an investment portfolio maintained
and managed by SSgA Funds Management, Inc. (&ldquo;SSFM&rdquo;). SSFM is the investment advisor to separate investment portfolios, including
the SPDR<SUP>&reg;</SUP> S&amp;P<SUP>&reg;</SUP> Biotech ETF. The SPDR<SUP>&reg;</SUP> S&amp;P<SUP>&reg;</SUP> Biotech ETF seeks to provide investment results that correspond generally
to the price and yield performance, before fees and expenses, of the S&amp;P<SUP>&reg;</SUP> Biotechnology Select Industry Index. The S&amp;P<SUP>&reg;</SUP>
Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the Standard &amp; Poor&rsquo;s Total Market
Index (&ldquo;S&amp;P TMI&rdquo;), an index that is designed to measure the performance of the U.S. equity market. The SPDR<SUP>&reg;</SUP> S&amp;P<SUP>&reg;</SUP>
Biotech ETF trades on NYSE Arca under the ticker symbol &ldquo;XBI.&rdquo;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">In seeking to track the performance of the S&amp;P<SUP>&reg;</SUP> Biotechnology
Select Industry Index, the SPDR<SUP>&reg;</SUP> S&amp;P<SUP>&reg;</SUP> Biotech ETF employs a sampling strategy, which means that the Fund is not required to
purchase all of the securities represented in the S&amp;P<SUP>&reg;</SUP> Biotechnology Select Industry Index. Instead, the S&amp;P<SUP>&reg;</SUP> Biotechnology
Select Industry Index may purchase a subset of the securities in the S&amp;P<SUP>&reg;</SUP> Biotechnology Select Industry Index in an effort to
hold a portfolio of securities with generally the same risk and return characteristics of the S&amp;P<SUP>&reg;</SUP> Biotechnology Select Industry
Index. The SPDR<SUP>&reg;</SUP> S&amp;P<SUP>&reg;</SUP> Biotech ETF will normally invest at least 80% of its total assets in the common stocks that comprise
the S&amp;P<SUP>&reg;</SUP> Biotechnology Select Industry Index.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">The S&amp;P<SUP>&reg;</SUP> Biotechnology Select Industry<SUP>&reg;</SUP> Index</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">The S&amp;P<SUP>&reg;</SUP> Biotechnology Select Industry Index represents the
biotechnology segment of the S&amp;P TMI. The biotechnology segment of the S&amp;P TMI comprises the Biotechnology sub-industry. The S&amp;P<SUP>&reg;</SUP>
Biotechnology Select Industry Index is one of 21 of the S&amp;P Select Industry Indices (the &ldquo;Select Industry Indices&rdquo;), each
designed to measure the performance of a narrow sub-industry or group of sub-industries determined based on the Global Industry Classification
Standard (&ldquo;GICS&rdquo;). Membership in the Select Industry Indices is based on the GICS classification, as well as liquidity and
market cap requirements. Companies in the Select Industry Indices are classified according to GICS which determines classifications primarily
based on revenues; however, earnings and market perception are also considered. The S&amp;P<SUP>&reg;</SUP> Biotechnology Select Industry Index consists
of the S&amp;P TMI constituents belonging to the Biotechnology sub-industry that satisfy the following criteria:</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;have a float-adjusted market capitalization greater than or
equal to $500 million with a float-adjusted liquidity ratio (defined by dollar value traded over the previous 12 months divided by the
float-adjusted market capitalization as of the index rebalancing reference date) greater than or equal to 90% or have a float-adjusted
market capitalization greater than or equal to $400 million with a float-adjusted liquidity ratio (as defined above) greater than or equal
to 150%; and</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;are U.S. based companies.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">The S&amp;P<SUP>&reg;</SUP> Biotechnology Select Industry Index is modified equal
weighted.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">To evaluate liquidity, the dollar value traded for initial public offerings
or spin-offs that do not have 12 months of trading history is annualized. If there are fewer than 35 stocks, stocks from the Life Sciences
Tools &amp; Services sub-industry that meet the market capitalization and liquidity thresholds are included in order of their float-adjusted
market capitalization from largest to smallest. If there continues to be fewer than 22 stocks, the market capitalization threshold may
be relaxed to ensure that there are at least 22 stocks in the S&amp;P<SUP>&reg;</SUP> Biotechnology Select Industry Index as of the rebalancing effective
date. Existing index constituents are removed at the quarterly rebalancing effective date if either their float-adjusted market capitalization
falls below $300 million or their float-adjusted liquidity ratio falls below 50%. The market capitalization threshold and the liquidity
threshold are each reviewed from time to time based on market conditions.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="text-align: right; width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">The S&amp;P<SUP>&reg;</SUP> Biotechnology Select Industry Index rebalances and
reconstitutes quarterly on the third Friday of the quarter ending month. The reference date for additions and deletions is after the close
of the last trading date of the previous month. The S&amp;P TMI tracks all eligible U.S. common equities listed on the NYSE, NYSE Arca,
NYSE American, NASDAQ Global Select Market, NASDAQ Select Market, NASDAQ Capital Market, Cboe BZX, Cboe BYX, Cboe EDGA, or Cboe EDGX exchanges.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>





<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">19</P>
<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 2px solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>bmologosm.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 bmologosm.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!F17AI9@  34T *@    @ ! $:  4
M   !    /@$;  4    !    1@$H  ,    !  (   $Q  (    0    3@
M      !@     0   &     !<&%I;G0N;F5T(#4N,"XW /_; $,  0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_  !$( "<
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MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$
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MEDF9UYXK!8J67X_-,+7IULKG[*G.CC*52>$S#!3YJ<XX?$17+_77^R'\>O\
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M-W_:FL:K%KNEE9&6SU(Q6-Y*5CFEAB)>&O9+K]BG2+W]H[P-^U'<?&7XJO\
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MIT(U85HXBEBVY2C[.4DYR7B/Q$^-W[0?BO\ X*)?L'^'_ 7Q2_X0[X8_&O\
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M-_\ @VD$NL32?#?]JAK+09)6:"S\:_#D:EJEM"3E(6OM$\1:9;W31CY?.-G
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+ %% !10 44 ?_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
